{
    "organizations": [],
    "uuid": "50edc4166c77c50156359c64c10a83fdae7ba0cb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-chembiodiagnosticsand-lumiradx-ent/brief-chembiodiagnosticsand-lumiradx-enter-collaboration-to-develop-new-point-of-care-diagnostic-tests-for-infectious-diseases-idUSFWN1S2130",
    "ord_in_thread": 0,
    "title": "BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Chembio Diagnostics Inc:\n* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES\n* CHEMBIO DIAGNOSTICS INC - WILL RECEIVE FUNDING FROM LUMIRADX, SUBJECT TO CERTAIN MILESTONES, TO DEVELOP CERTAIN NEW POC INFECTIOUS DISEASE TESTS\n* CHEMBIO DIAGNOSTICS INC - AGREEMENT INCLUDES POTENTIAL DEVELOPMENT OF A VARIETY OF NEW POC TESTS\n* CHEMBIO DIAGNOSTICS - FOLLOWING REGULATORY APPROVAL, COMMERCIALIZATION, CO WILL SELL REAGENTS TO, RECEIVE ROYALTY PAYMENTS FROM, LUMIRADX ON SALES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T20:10:00.000+03:00",
    "crawled": "2018-04-26T20:45:47.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "chembio",
        "diagnostics",
        "inc",
        "chembio",
        "diagnostics",
        "lumiradx",
        "enter",
        "collaboration",
        "develop",
        "new",
        "diagnostic",
        "test",
        "infectious",
        "disease",
        "chembio",
        "diagnostics",
        "inc",
        "receive",
        "funding",
        "lumiradx",
        "subject",
        "certain",
        "milestone",
        "develop",
        "certain",
        "new",
        "poc",
        "infectious",
        "disease",
        "test",
        "chembio",
        "diagnostics",
        "inc",
        "agreement",
        "includes",
        "potential",
        "development",
        "variety",
        "new",
        "poc",
        "test",
        "chembio",
        "diagnostics",
        "following",
        "regulatory",
        "approval",
        "commercialization",
        "co",
        "sell",
        "reagent",
        "receive",
        "royalty",
        "payment",
        "lumiradx",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}